IN
Inovio Pharmaceuticals, Inc.
INO · NASDAQ
$1.24 +0.00% (+$0.00)
1M -0.80%
Market Cap $85.7M
P/E Ratio -
Div. Yield -
ROE 1,005.80%
Bulios Fair Price
$0.94
24.2% downside
Trenutna cena
$1.24
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica INO trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
0/9Valuation
0 /100
Expensive P/B 19.60x
P/FFO N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 52.32%
Rev. growth 81.47%
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 1,005.80%
ROA 136.52%
Asset turnover 0.00x
Debt
28 /100
High Current ratio 1.00x
Debt/Equity 1.83x
Net debt/EBITDA N/A
Stability
62 /100
Moderate Rev. volatility 11.70%
EPS volatility 11.79%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o INO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jacqueline E. Shea
Employees
112
Headquarters
Plymouth Meeting
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report